4-aminobenzamidine has been researched along with transforming growth factor beta in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayukawa, K; Kawasaki, S; Miyagawa, S; Nomura, K; Soeda, J; Taniguchi, S | 1 |
1 other study(ies) available for 4-aminobenzamidine and transforming growth factor beta
| Article | Year |
|---|---|
Inhibition of urokinase-type plasminogen activator delays expression of c-jun, activated transforming growth factor beta 1, and matrix metalloproteinase 2 during post-hepatectomy liver regeneration in mice.
Topics: Animals; Benzamidines; Cell Division; Hepatectomy; Hepatocytes; Liver Regeneration; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Proto-Oncogene Proteins c-jun; RNA, Messenger; Serine Proteinase Inhibitors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Urokinase-Type Plasminogen Activator | 2002 |